Abstract:Outer membrane vesicles (OMV) derived from Bordetella pertussis— the etiologic agent of the resurgent disease called pertussis—are safe and effective in preventing bacterial colonization in the lungs of immunized mice. Vaccine formulations containing those OMV are capable of inducing a mixed Th1/Th2/Th17 profile, but even more interestingly, they may induce a tissue-resident memory immune response. This immune response is recommended for the new generation of pertussis-vaccines that must be developed to overcome the weaknesses of current commercial acellular vaccines (second-generation of pertussis vaccine). The third-generation of pertussis vaccine should also deal with infections caused by bacteria that currently circulate in the population and are phenotypically and genotypically different [in particular those deficient in the expression of pertactin antigen, PRN(-)] from those that circulated in the past. Here we evaluated the protective capacity of OMV derived from bacteria grown in biofilm, since it was observed that, by difference with older culture collection vaccine strains, circulating clinical B. pertussis isolates possess higher capacity for this lifestyle. Therefore, we performed studies with a clinical isolate with good biofilm-forming capacity. Biofilm lifestyle was confirmed by both scanning electron microscopy and proteomics. While scanning electron microscopy revealed typical biofilm structures in these cultures, BipA, fimbria, and other adhesins described as typical of the biofilm lifestyle were overexpressed in the biofilm culture in comparison with planktonic culture. OMV derived from biofilm (OMVbiof) or planktonic lifestyle (OMVplank) were used to formulate vaccines to compare their immunogenicity and protective capacities against infection with PRN(+) or PRN(-) B. pertussis clinical isolates. Using the mouse protection model, we detected that OMVbiof-vaccine was more immunogenic than OMVplank-vaccine in terms of both specific antibody titers and quality, since OMVbiof-vaccine induced antibodies with higher avidity. Moreover, when OMV were administered at suboptimal quantity for protection, OMVbiof-vaccine exhibited a significantly adequate and higher protective capacity against PRN(+) or PRN(-) than OMVplank-vaccine. Our findings indicate that the vaccine based on B. pertussis biofilm-derived OMV induces high protection also against pertactin-deficient strains, with a robust immune response.

The effects of manufacture processes on post-translational modifications of bioactive proteins in pertussis vaccine

Development of a method for in vitro determination of toxicity of acellular pertussis vaccine

Study on Purification and Biological Characteristics of Pertactin from Bordetella Pertussis

Development and biological properties of an attenuated Bordetella pertussis strain

The mature c-terminal domain of filamentous hemagglutinin is sufficient to provide protection against Bordetella pertussisin the murine nasal cavity

Protection Role of Active Pertussis Toxin in Acellular Pertussis Vaccine

Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1

Outer membrane proteins of Bordetella pertussis function as a modulator on promoting degranulation of mastocyte in vitro

[Determination of tracheal cytotoxin in pertussis and diphtheria tetanus acellular pertussis vaccines using liquid chromatography-tandem mass spectrometry]

Novel manufacturing process of pneumococcal capsular polysaccharides using advanced sterilization methods

Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines

Establishment of the Sixth Generation of National Standard for Potency Assay of Pertussis Vaccine

Deep longitudinal multi-omics analysis of Bordetella pertussis cultivated in bioreactors highlights medium starvations and transitory metabolisms, associated to vaccine antigen biosynthesis variations and global virulence regulation

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

Effects of detoxification process on toxicity and foreign protein of tetanus toxoid and diphtheria toxoid

In Vitro Activity and Clinical Efficacy of Macrolides, Cefoperazone-Sulbactam and Piperacillin/piperacillin-Tazobactam Against Bordetella Pertussis and the Clinical Manifestations in Pertussis Patients Due to These Isolates: A Single-Centre Study in Zhejiang Province, China.

Subcutaneous administration of a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis induces mucosal and systemic immune responses

Simplified Process for Preparing Native and Depolymerized Capsular Polysaccharides of Streptococcus Pneumoniae

Direct Molecular Typing of Bordetella Pertussis from Nasopharyngeal Specimens in China in 2012–2013

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture

Antibody Profiles Elicited by Potent and Subpotent Whole Cell Pertussis Vaccines in Mice